JUNE 20255LIFE SCIENCES REVIEWCXO INSIGHTSBiotechnology Should have Preferred Regulatory Pathways to Catalyze the Bioscience RevolutionLone Dybdal Nilsson, VP of Applied Research in Agriculture and Industrial Bioprocessing, Novozymes31Advancing Clinical Development Through Translational PrecisionKeiji Furuuchi, PhD, Discovery Leader, IPT for BB1701 Clinical Development, Eisai US30Bridging the Diversity DivideVictoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc.3228Dr. Atul Tandon,President and CEOLisa Moneymaker,Head of Strategic Customer EngagementMedidataNeoBiotechnologiesInnovating Clinical Trials Through Technology StrategyMike Mendoza, Executive Director, eClinical Technology Strategy and Biometrics, TFS HealthScience24The Rub: Medical Affairs is Far More than a Commodity in Rare and Genetic DiseaseHenry David Cremisi, MD FACP, Executive Medical Director, Medical Affairs, Caidya18STATE OF THE INDUSTRYTop Monoclonal Antibody Solution Provider 2025Unified Life Sciences Platform Company of the Year 202512Medical Affairs Service Providers: Architecting the Future of Life Sciences20Unified Platforms Reshaping the Life Sciences Industry26Advancing Precision Medicine with Monoclonal Antibody Development 22
< Page 4 | Page 6 >